SaurabhZanwarMD

PubMed

• Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures.
  Saurabh Zanwar, Morie A Gertz, Eli Muchtar, Francis K Buadi, Taxiarchis Kourelis, Wilson Gonsalves, Ronald S Go, Suzanne Hayman, Prashant Kapoor, Moritz Binder, Josell...> ;Leukemia. 2024 Apr 9
• Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis.
  Gordon J Ruan, Saurabh Zanwar, Aishwarya Ravindran, Susan Schram, Jithma P Abeykoon, Antonious Hazim, Jason R Young, Mithun V Shah, N Nora Bennani, Liuyan Jiang, Diana...> ;American Journal of Hematology. 2024 May 1
• The immunome of mobilized peripheral blood stem cells is predictive of long-term outcomes and therapy-related myeloid neoplasms in patients with multiple myeloma under...
  Saurabh Zanwar, Eapen K Jacob, Carl Greiner, Kevin Pavelko, Michael Strausbauch, Emilie Anderson, Arini Arsana, Megan Weivoda, Mithun Vinod Shah, Taxiarchis Kourelis> ;Blood Cancer Journal. 2023 Sep 26
• 4 citations
  Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer.
  Aakash Desai, Caleb J Smith, Yash Ashara, Jacob J Orme, Saurabh Zanwar, Ashley Potter, Craig Hocum, J Nicole Moffett, Anna J Schwecke, Rami Manochakian, Yanyan Lou, Yu...> ;Clinical Lung Cancer. 2023 Dec 1
• 2 citations
  Long-term outcomes among adults with Langerhans cell histiocytosis.
  Gaurav Goyal, Aldo A Acosta-Medina, Jithma P Abeykoon, Chen Dai, Aishwarya Ravindran, Robert Vassallo, Jay H Ryu, Mithun V Shah, N Nora Bennani, Jason R Young, Corrie ...> ;Blood Advances. 2023 Nov 14
• Chimeric antigen receptor T-cell therapy in hematologic malignancies: Successes, challenges, and opportunities.
  Matthew Ho, Saurabh Zanwar, Jonas Paludo> ;European Journal of Haematology. 2024 Feb 1
• 5 citations
  Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
  Saurabh Zanwar, Matthew Ho, Yi Lin, Prashant Kapoor, Moritz Binder, Francis K Buadi, Angela Dispenzieri, David Dingli, Amie Fonder, Morie A Gertz, Wilson Gonsalves, Su...> ;American Journal of Hematology. 2023 Oct 1
• 2 citations
  Malignant Histiocytosis Comprises a Phenotypic Spectrum That Parallels the Lineage Differentiation of Monocytes, Macrophages, Dendritic Cells, and Langerhans Cells.
  Aishwarya Ravindran, Surendra Dasari, Gordon J Ruan, Cody J Artymiuk, Rong He, David S Viswanatha, Jithma P Abeykoon, Saurabh Zanwar, Jason R Young, Gaurav Goyal, Rona...> ;Modern Pathology. 2023 Oct 1
• Central nervous system involvement (Bing-Neel Syndrome) in patients with Waldenström macroglobulinemia.
  Saurabh Zanwar, Jithma P Abeykoon, Stephen M Ansell, Morie A Gertz, Michelle Mauermann, Thomas E Witzig, Patrick Johnston, Robert A Kyle, Rebecca L King, Thomas M Habe...> ;Leukemia & Lymphoma. 2023 Jun 10
• 2 citations
  Immunoglobulin Light Chain Amyloidosis: Diagnosis and Risk Assessment.
  Saurabh Zanwar, Morie A Gertz, Eli Muchtar> ;Journal of the National Comprehensive Cancer Network. 2023 Jan 1
• Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.
  Saurabh Zanwar, Matthew Ho, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Raf...> ;Blood Cancer Journal. 2022 Nov 24
• 11 citations
  Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment.
  Matthew Ho, Alexander Xiao, Dongni Yi, Saurabh Zanwar, Giada Bianchi> ;Current Oncology. 2022 Nov 21
• 15 citations
  Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis.
  Matthew Ho, Saurabh Zanwar, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Raf...> ;American Journal of Hematology. 2023 Jan 1
• 13 citations
  Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status.
  Jithma P Abeykoon, Karen L Rech, Jason R Young, Aishwarya Ravindran, Gordon J Ruan, Surendra Dasari, Diana M Morlote, Rebecca L King, Claire Rummage, Saurabh Zanwar, A...> ;JAMA Oncology. 2022 Dec 1
• 2 citations
  Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance.
  Matthew Ho, Saurabh Zanwar, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Raf...> ;Blood. 2022 Nov 3
• 3 citations
  High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia.
  Eric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, Elise Toussaint, Efstathios Kastritis, Shirley D'Sa, Miguel Alcoceba, Cécile Tomowiak, Bénédicte Hivert, Caroline Prot...> ;Blood Advances. 2022 Jun 28
• 5 citations
  Clinical and therapeutic implications of BRAF fusions in histiocytic disorders.
  Saurabh Zanwar, Jithma P Abeykoon, Surendra Dasari, Jason R Young, Aldo A Acosta-Medina, Karen L Rech, Jonathan Schwartz, Aaron Mangold, Allison Rosenthal, N Nora Benn...> ;Blood Cancer Journal. 2022 Jun 28
• 2 citations
  Prolonged remission with pembrolizumab and radiation therapy in a patient with multisystem Langerhans cell sarcoma.
  Saurabh Zanwar, Aishwarya Ravindran, Jithma P Abeykoon, Jason R Young, Timothy F Kozelsky, Karen L Rech, Gaurav Goyal, Ronald S Go> ;Haematologica. 2022 Sep 1
• 4 citations
  Treatment paradigm in Waldenström macroglobulinemia: frontline therapy and beyond.
  Saurabh Zanwar, Jithma P Abeykoon> ;Therapeutic Advances in Hematology. 2022 Jan 1
• 44-Year-Old Man With Anemia, Thrombocytopenia, and Acute Kidney Injury.
  Sauraubh Zanwar, Morie A. Gertz> ;Mayo Clinic Proceedings. 2021 Nov 30
• Hiding in (Not So) Plain Sight: Spontaneous Tumor Lysis Syndrome due to Intravascular Large B Cell Lymphoma
  Saurabh Zanwar, Patrick Duggan, Ryan M. Carr, Thomas M. Habermann, Patrick J. Navin, Mohamed E. Salama, Sameer A. Parikh> ;American Journal of Hematology. 2021 Oct 22
• 11 citations
  Outcomes of triple class (proteasome inhibitor, IMiDs and monoclonal antibody) refractory patients with multiple myeloma.
  , , , , , , , , , , , , , , , , , , > ;Leukemia. 2021 Oct 11
• 9 citations
  The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM).
  , , , , , , , , , , , , , , , , , > ;Blood Cancer Journal. 2021 Sep 22
• 13 citations
  Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia.
  Saurabh Zanwar, Jithma P. Abeykoon, Stephen M. Ansell, Morie A. Gertz, Colin L. Colby, Dirk R. Larson, Jonas Paludo, Rong He, Rahma Warsame, Patricia T. Greipp, Rebecc...> ;British Journal of Haematology. 2021 Aug 2
• 3 citations
  Disease heterogeneity, prognostication and the role of targeted therapy in multiple myeloma.
  Saurabh Zanwar, Shaji Kumar> ;Leukemia & Lymphoma. 2021 Jul 24
• Join now to see all

Journal Articles

• Primary Systemic Amyloidosis in Patients with Waldenström Macroglobulinemia  
  Angela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature
• Daratumumab-Based Therapy in Patients with Heavily-Pretreated AL Amyloidosis  
  Saurabh Zanwar, Angela Dispenzieri, Wilson Gonsalves, David Dingli, Jithma P Abeykoon, Martha Q Lacy, Shaji Kumar, Nelson Leung, Morie A Gertz, Eli Muchtar, Francis Bu..., Nature

Lectures

• Rituximab-based maintenance therapy in Waldenström macroglobulinemia: A case control study. 
  2019 ASCO Annual Meeting - 6/1/2019
• Predictors of disease progression in smoldering Waldenstram macroglobulinemia. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018